UPDATE Jan. 5, 2021 2:30 p.m. EST—Shortly after we published today’s issue, Pharmaceutical Research and Manufacturers of America (PhRMA) responded to our request for comment on the U.S. Health and Human Services (HHS) General Counsel’s Dec. 30 advisory opinion on 340B contract pharmacy.
PhRMA said:
Chicago Tribune, one of the nation’s largest daily newspapers, yesterday published a front-page, nearly 2,000-word article about drug manufacturers’ denials of 340B pricing on medications dispensed by contract pharmacies.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
